Early- to late-stage life science companies have until July 31 to submit applications to present at the 2018 Southeast BIO Investor & Partnering Forum to be held in Atlanta November 13-14.

Presenting at the forum provides visibility among potential investors and industry partners and an audience of 350-plus attendees. It provides a showcase for promising bioscience and medical technology companies in the organization’s seven-state region of North Carolina, Alabama, Florida, Georgia, South Carolina, Tennessee and Virginia.

The privately held companies are selected by a panel of judges.

Early-stage companies selected to present also receive a private advisory session with experienced business professionals.

Company representatives receive complementary registration and access to SEBIO Connect to schedule one-on-one meetings. Early-stage companies have no prior institutional funding and management teams may be limited to an academic investigator or principal founder.

Each early-stage company representative will also have the option to participate in a 30-minute, web/teleconference-based virtual presentation and consultation session two to four weeks before the forum.

On site at the forum, each company will meet with a specifically matched advisory panel during an interactive, hour-long session. Advisory panels are composed of six to eight individuals from active life science venture funds, experienced life science managers, serial entrepreneurs, and service providers. The company representatives will present their opportunity, including their “elevator pitch,” 10- to 12-minute PowerPoint presentation, and business plan.

Main stage presenters will have completed one or more investment rounds from qualified venture firms, have active management teams, and are advanced in their technology development cycle.

Main stage presentations

The main stage company session will consist of alternating company presentations with panel discussions featuring company success stories and/or hot topics. Selected companies will be allotted approximately 10 minutes to present and a single-track format will be followed so all conference attendees have the opportunity to view all presentations.

All selected companies are also included in conference materials before, during and after the event, such as the conference website and mobile app.

Since 1999, more than 200 venture-backed companies have presented on the main stage, and more than 150 companies have participated in the early-stage program. Public and private follow-on funding for companies presenting at the forum has topped $2.5 billion, not including recent acquisitions valued at over $13 billion, according to SEBIO.

Venture funds that regularly attend include:
GR Venture Fund; Harbert Venture Partner; Hatteras Venture Partners ;  HealthQuest Ventures; H.I.G. Capital ; J&J Development Corporation; Lilly Ventures; Lumira Capital; Merck; MPM Capital; New Enterprise Associates; Osage University Partners; Pappas Capital; Pappas Ventures; Southeast Investor Group; SR One; and many more.

The North Carolina Biotechnology Center is a sponsor of the event.